Bizma Investimentos Ltda Bristol Myers Squibb CO Transaction History

Bizma Investimentos Ltda

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Oct 07, 2022	SELL	$61.48 - $73.72 $4.3 Million - $5.16 Million	-70,000 Reduced 43.75%	90,000 $6.77 Million
Q4 2019 Oct 07, 2022	SELL	$49.21 - $64.19 $1.97 Million - $2.57 Million	-40,000 Reduced 20.0%	160,000 $10.3 Million
Q2 2019 Oct 07, 2022	BUY	$44.62 - $49.34 $8.92 Million - $9.87 Million	200,000 New	200,000 $9.07 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bizma Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Bizma Investimentos Ltda with notifications on news.